Back to Blog
Blue apron cost per month5/16/2023 ![]() Data shows 16.3% of the float short and a cost to borrow of 23.6%. ![]() The stock moves back into the top five positions, ranking third for the week after moving up eight positions. Blue Apron Holdings APRN: Meal kit company Blue Apron has been a popular short squeeze candidate over the last two years for retail traders. The company also announced recently that two abstracts have been accepted to present at the 1st International Societies for Investigative Dermatology Meeting in Japan from May 10 to May 13. Wainwright reiterated a Buy rating and $20 price target on ASLAN, which trades at $3 a share, on Monday morning. Data shows 41.3% of the float short and a cost to borrow of 13.9%. ![]() The company moves up 221 places to rank second for the week. ASLAN Pharmaceuticals ASLN: Making one of the biggest moves of the week is clinical-stage biopharmaceutical company ASLAN. The cost to borrow for PaxMedica ranks second on the short squeeze leaderboard for the week. Data shows 33.2% of the float short and a cost to borrow of 464%. The company moves up seven positions to top the list. PaxMedica Inc PXMD: Clinical-stage biopharmaceutical company PaxMedica moves back into the top five short squeeze candidates, after weeks of moving up the leaderboard. Here’s a look at the top five short squeeze candidates this week based on the Fintel short squeeze leaderboard. ![]() High short interest and a high cost to borrow are among the common traits that could lead to a short squeeze. Potential short squeeze plays gained steam in 2021 and continued through 2022 with new traders looking for the next huge move. Two stocks moves up hundreds of places on the short squeeze leaderboard. 10 Short Squeeze Candidates: PaxMedica, Blue Apron, MicroStrategy And More
0 Comments
Read More
Leave a Reply. |